NCT06846151Not yet recruiting
Retinal Investigation Using Optos OCT Device
Clinical Investigation of Optos OCT in Patients with Retinal Pathologies
Source: ClinicalTrials.gov · Last updated 25 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Retinal investigation using OCT with control and diseased eyes
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 13 Feb 2025
- Start date
- 1 May 2025
- Primary completion date
- 30 Nov 2025
- Lead sponsor
- Optos, PLC
- NCT number
- NCT06846151
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 1 May 2025 to the primary completion date, 30 Nov 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Ophthalmic disease other than condition under investigation.
- Diabetes (unless part of the diabetic eye disease group)
- Participants with photo sensitivity epilepsy, experience of seizures, or sensitivity to flickering light (based on self-report)
Age
- Age related macular degeneration groups: polypoidal choroidal vasculopathy
Other
- Inability to understand written and verbal English sufficiently to comprehend the study and provide informed consent
- Participants unable to tolerate ophthalmic imaging.
- Cataract (unless deemed mild in the opinion of the investigator)
- Participants with significant ocular media not sufficiently clear to obtain acceptable OCT images.
- Binocular visual acuity worse than 6/18
- Strabismus (squint)
- Pregnant
Who the study is looking for
- Male or female participants 18 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed.
- Participants who understand the study and patient information sheet and can follow the instructions.
- Participants who agree to participate in the study.
- Control group where no retinal abnormalities were detected as part of the standard basic ophthalmic examination.
- Participants with retinal disease in at least one eye including: Early dry age-related macular degeneration, late stage dry age-related macular degeneration specifically geographic atrophy, Wet age-related macular degeneration, Retinitis pigmentosa, Diabetic retinopathy and other macular atrophic diseases
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.